Patient care

MediScan® in the US

MediScan® in the US

As part of the MediScan® portfolio, LMS-Lung/Track and LMS-Liver are Food and Drug Administration (FDA) cleared and available as standalone or bundled solutions.

LMS-Lung/Track

LMS-Lung/Track software is designed for evaluating and following-up lesions identified in CT images of the chest. It provides a quantitative assessment of therapeutic response in oncology patients, including those enrolled in clinical trials, and facilitates evaluation and follow-up of indeterminate lung nodules.

Key features

  • Quantitative assessment of therapeutic response in oncology imaging
  • Automatic generation of RECIST reports
  • Automatic lesion follow-up
  • 3D segmentation and automatic measurement of hypodense liver lesions
  • 2D measurement and reporting of nodal and other lesions

LMS-Liver

LMS-Liver software is built for evaluating and following-up liver metastases and other lesions identified in CT images of the liver. It provides a quantitative assessment of therapeutic response in oncology patients, including those enrolled in clinical trials.

Key features

  • Quantitative assessment of therapeutic response in oncology imaging
  • Automatic generation of RECIST reports
  • Automatic lesion follow-up
  • 3D segmentation and automatic measurement of hypodense liver lesions
  • 2D measurement and reporting of nodal and other lesions

MEDIAN support team contacts

support@mediantechnologies.com

MediScan® outside the US

Cookies help us deliver our services. By using our services, you agree to our use of cookies.